U.S. PHARMACOPEIA

Search USP29  
Triamterene and Hydrochlorothiazide Capsules
» Triamterene and Hydrochlorothiazide Capsules contain not less than 90.0 percent and not more than 110.0 percent of the labeled amounts of triamterene (C12H11N7) and hydrochlorothiazide (C7H8ClN3O4S2).
NOTE—The Capsules and Tablets dosage forms should not be considered bioequivalent. If patients are to be transferred from one dosage form to the other, retitration and appropriate changes in dosage may be necessary.
Packaging and storage— Preserve in tight, light-resistant containers.
Labeling— Label the Capsules to indicate the Dissolution test with which the product complies.
Identification—
A: Thin-Layer Identification Test 201
Test solution— Dissolve a portion of the Capsule contents, equivalent to about 50 mg of triamterene, in 25 mL of methoxyethanol, mix, and filter. Use the filtrate as the Test solution.
Standard solution 1— Prepare a solution of USP Triamterene RS in methoxyethanol containing about 2 mg per mL.
Standard solution 2: a sufficient quantity of USP Hydrochlorothiazide RS in methoxyethanol to obtain a solution having a concentration similar to that of the Test solution.
Application volume: 2 µL.
Developing solvent system: a mixture of ethyl acetate, glacial acetic acid, and water (8:1:1).
Procedure— Locate the spots under short-wavelength and long-wavelength UV light: the intensity and RF value correspond to that obtained from Standard solution 1 and Standard solution 2.
B: The retention times of the major peaks in the chromatogram of the Assay preparation correspond to those in the chromatogram of the Standard preparation, as obtained in the Assay.
Dissolution 711
TEST 1: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 1.
Medium: 0.1 M acetic acid containing 1% polysorbate 20; 900 mL.
Apparatus 2: 100 rpm.
Time: 120 minutes.
Procedure— Determine the amounts of triamterene (C12H11N7) and hydrochlorothiazide (C7H8ClN3O4S2) dissolved from UV absorption at the wavelength of maximum absorbance at about 357 nm for triamterene and 271 nm for hydrochlorothiazide (corrected for interference from triamterene on the basis of the absorbances of triamterene at 271 nm and 357 nm) on a filtered portion of the solution under test, suitably diluted with water, in comparison with a Standard solution having known concentrations of USP Triamterene RS and USP Hydrochlorothiazide RS in the same Medium.
Tolerances— Not less than 80% (Q) of the labeled amounts of C12H11N7 and C7H8ClN3O4S2 is dissolved in 120 minutes.
TEST 2: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 2.
Medium: 4.0% tetrasodium ethylenediaminetetraacetate, 2.0% polysorbate 40, 0.05% pancreatin; 900 mL. Prepare a solution using the following procedure. Add the polysorbate 40 and the tetrasodium ethylenediaminetetraacetate to water, and mix thoroughly. Adjust with phosphoric acid to a pH of 8.0 ± 0.05. Heat to 37, and add the pancreatin powder. Mix thoroughly, and transfer immediately to the dissolution vessel.
Apparatus 1 (use 10-mesh baskets): 100 rpm.
Time: 8 hours.
Mobile phase— Prepare a filtered and degassed solution of 0.08 M monobasic sodium phosphate buffer and methanol (3:1). Make adjustments if necessary (see System Suitability under Chromatography 621).
Standard preparation— Transfer about 110 mg of USP Triamterene RS and about 55 mg of USP Hydrochlorothiazide RS, each accurately weighed, to a 500-mL volumetric flask. Add 100 mL of methanol, sonicate for 10 minutes, and heat in a steam bath until completely dissolved. Dilute with Medium to volume, and mix. Transfer 25 mL of this solution into a 100-mL volumetric flask, dilute with Medium to volume, and mix gently to minimize foaming.
Test preparation— Filter a portion of the solution under test. [NOTE—Do not use nylon filters.]
Chromatographic system (see Chromatography 621)— The liquid chromatograph is equipped with a 254-nm detector, a guard column that contains packing L7, and an analytical 3.9-mm × 30-cm column that contains packing L11. The flow rate is about 2 mL per minute. Chromatograph the Standard preparation, and record the responses as directed for Procedure: the resolution, R, between the triamterene and hydrochlorothiazide peaks is not less than 2.0; and the relative standard deviation for replicate injections of each analyte is not more than 2.0%.
Procedure— Separately inject equal volumes (about 50 µL) of the Standard preparation and the Test preparation in the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantities, in mg, of triamterene (C12H11N7) and hydrochlorothiazide (C7H8ClN3O4S2) dissolved by the formula:
900C(rU / rS),
in which C is the concentration, in mg per mL, of the appropriate USP Reference Standard in the Standard preparation; and rU and rS are the peak responses of the relevant analyte obtained from the Test preparation and the Standard preparation, respectively.
Tolerances— Not less than 70% (Q) of the labeled amount of C12H11N7 and not less than 80% (Q) of the labeled amount of C7H8ClN3O4S2 are dissolved in 8 hours.
TEST 3: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 3.
Medium: 0.1 N hydrochloric acid; 900 mL.
Apparatus 1: 100 rpm.
Time: 45 minutes.
Procedure— Proceed as directed for Test 1.
Tolerances— Not less than 75% (Q) of the labeled amounts of C12H11N7 and C7H8ClN3O4S2 is dissolved in 45 minutes.
Uniformity of dosage units 905: meet the requirements for Content Uniformity with respect to triamterene and to hydrochlorothiazide.
Related compounds—
Solution A, Solution B, Mobile phase, Standard solution, and Chromatographic system— Proceed as directed for the Related compounds test under Triamterene and Hydrochlorothiazide Tablets.
Test solution— Remove, as completely as possible, the contents of not fewer than 20 Capsules, and weigh accurately. Mix the combined contents, and transfer an accurately weighed portion of the powder, equivalent to about 150 mg of hydrochlorothiazide, to a 100-mL volumetric flask. Add 60 mL of acetonitrile and 6 mL of glacial acetic acid, and sonicate for 10 minutes. Cool, dilute with water to volume, mix, and filter.
Procedure— Proceed as directed for Procedure in the Related compounds test under Triamterene and Hydrochlorothiazide Tablets. Calculate the quantity, in mg, of benzothiadiazine related compound A in the hydrochlorothiazide contained in the portion of Capsules taken by the formula:
100C(rU / rS),
in which C is the concentration, in mg per mL, of USP Benzothiadiazine Related Compound A RS in the Standard solution; and rU and rS are the peak areas of benzothiadiazine related compound A obtained from the Test solution and the Standard solution, respectively: not more than 1.0% is present.
Residual solvents 467: meet the requirements.
(Official January 1, 2007)
Assay—
Buffer solution, Mobile phase, and Standard preparation— Proceed as directed in the Assay under Triamterene and Hydrochlorothiazide Tablets.
Assay preparation— Remove, as completely as possible, the contents of not fewer than 20 Capsules, combine the contents, and transfer an accurately weighed portion of powder, equivalent to about 50 mg of hydrochlorothiazide, to a 200-mL volumetric flask. Add 20 mL of acetonitrile, and sonicate for 10 minutes. Add 20 mL of boiling water, sonicate for 5 minutes, and mix. Add 10 mL of acetic acid, sonicate for 10 minutes, and mix. Add 140 mL of water, mix, and allow to cool to room temperature. Dilute with water to volume, mix, and filter, discarding the first 3 mL of the filtrate.
Chromatographic system (see Chromatography 621)— The liquid chromatograph is equipped with a 280-nm detector and a 3.9-mm × 30-cm column that contains packing L1. The flow rate is about 1 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the relative retention times are 0.65 for hydrochlorothiazide and 1.0 for triamterene; the resolution, R, between hydrochlorothiazide and triamterene is not less than 3.0; and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure— Separately inject equal volumes (about 10 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses of the major peaks. Calculate the quantity, in mg, of triamterene (C12H11N7) in the portion of Capsules taken by the formula:
200C(rU / rS),
in which C is the concentration, in mg per mL, of USP Triamterene RS in the Standard preparation; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively. Calculate the quantity, in mg, of hydrochlorothiazide (C7H8ClN3O4S2) in the portion of Capsules taken by the same formula, changing the terms to refer to hydrochlorothiazide.
Auxiliary Information— Staff Liaison : Andrzej Wilk, Ph.D., Senior Scientific Associate
Expert Committee : (MDCV05) Monograph Development-Cardiovascular
USP29–NF24 Page 2190
Pharmacopeial Forum : Volume No. 29(3) Page 672
Phone Number : 1-301-816-8305